AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2021
Dec 30, 2021
29745_dirs_2021-12-30_09511f7e-bebf-4f96-af6d-28ddcd1227e0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2021-12-28
Reporting Person: Van Naarden Jacob (SVP, CEO LoxoONC, Pres LlyONC)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-28 | Restricted Stock Unit | $ | A | 3618 | Acquired | Common Stock (3618.0) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
F2: The restricted stock units vest on February 1, 2024.
More from ELI LILLY & Co
Regulatory Filings
2026
May 11
Prospectus
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Prospectus
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 20